Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy.

Siegmund, Mira; Pagel, Julia; Scholz, Tasja; Rupp, Jan; Härtel, Christoph; Lauten, Melchior

Siegmund, Mira; Pagel, Julia; Scholz, Tasja; Rupp, Jan; Härtel, Christoph; Lauten, Melchior.

Afiliación

Siegmund M; Department of Pediatrics, Pediatric Hematology and Oncology, University of Lübeck, 23538, Lübeck, Germany.
Pagel J; Department of Pediatrics, Pediatric Hematology and Oncology, University of Lübeck, 23538, Lübeck, Germany.
Scholz T; Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.
Rupp J; German Center for Infection Research (DZIF), partner site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
Härtel C; Department of Pediatrics, Pediatric Hematology and Oncology, University of Lübeck, 23538, Lübeck, Germany.
Lauten M; Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.

Mol Cell Pediatr ; 7(1): 5, 2020 Jun 09.

Article en En | MEDLINE | ID: mdl-32519027

Palabras clave

Biomarker; Childhood cancer; Cytokines; Febrile neutropenia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Mol Cell Pediatr Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google